Skip to main content
MDGL
NASDAQ Life Sciences

Rezdiffra Data Shows Reduced Cardiovascular, Liver Risk in MASH Patients

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$524.28
Mkt Cap
$12.088B
52W Low
$265
52W High
$615
52W Position info
98% above low
Off High info
15% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

MDGL sits 98% above its 52-week low of $265.

Summary

Madrigal Pharmaceuticals presented new Phase 3 and real-world data at the EASL Congress, demonstrating Rezdiffra's ability to reduce markers of cardiovascular and liver-related risk in MASH patients. The data showed improvements in key atherogenic lipids like LDL-C and Lp(a), and progressive improvements in risk scores for clinically significant portal hypertension in compensated MASH cirrhosis, a population currently lacking approved therapies. This positive data reinforces Rezdiffra's market position and expands its potential benefits beyond liver histology, addressing significant comorbidities and strengthening its long-term sales outlook. This follows the strong Q1 Rezdiffra sales reported earlier this month.

At the time of this announcement, MDGL was trading at $524.28 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.1B. The 52-week trading range was $265.00 to $615.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

MDGL - Latest Insights

MDGL
Nov 06, 2026, 5:30 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $399.93
Real-time Price: $395.00 info
Change: -$4.93 (-1%) info
Market Cap: $9.247B info
MDGL
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $408.99
Real-time Price: $395.00 info
Change: -$13.99 (-3%) info
Market Cap: $9.247B info
MDGL
Nov 03, 2026, 9:10 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $428.01
Real-time Price: $395.00 info
Change: -$33.01 (-8%) info
Market Cap: $9.247B info
MDGL
Nov 03, 2026, 8:08 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $477.00
Real-time Price: $395.00 info
Change: -$82.00 (-17%) info
Market Cap: $9.247B info
MDGL
Nov 03, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $431.16
Real-time Price: $395.00 info
Change: -$36.15 (-8%) info
Market Cap: $9.247B info